Zhirong Yang holds a bachelor degree in medicine and master degrees in epidemiology and in primary care research. Before joining the Primary Care Unit in 2015, he worked as a biostatistician in Shantou-Oxford Clinical Research Unit and as a research associate in the Centre of Post-marketing Safety Evaluation at Peking University, mainly responsible for study design, data collection and analysis. Zhirong’s previous research projects focused on diabetes, cardiovascular diseases, tuberculosis, acne, and skin and soft tissue diseases, involving evaluation of treatment effectiveness and safety, assessment of diagnostic test accuracy, exploration of environmental and genetic factors, and estimation of disease burden. In 2018 he worked as a research fellow in the Department of Population Medicine at Harvard University.
Zhirong’s current research interests are in the use of Clinical Practice Research Datalink and UK Biobank data and the evidence synthesis to inform the management of cardiovascular diseases. His projects are looking at statin use patterns among patients with stroke and association of vascular risk factors and relevant pharmacological treatments with post-stroke dementia.
Zhirong lectures in the Routine Data module for the MPhil course in Primary Care Research led by the Unit at Cambridge.
Yang Z, Edwards D, Massou E, Saunders CL, Mant J. Statin use and high-dose statin use after ischemic stroke in the UK:a retrospective cohort study. Clinical Epidemiology 2019;11:495-508.
Yang Z, Hu J, Qu Y, Sun F, Leng X, Li H, Zhan S. Interventions for treating gas gangrene. Cochrane Database of Systematic Reviews 2015; 12: CD010577.
Yang Z, Wang J, Wang W, Zhang Y, Han L, Zhang Y, Nie X, Zhan S. Proportions of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in patients with surgical site infections in mainland China: a systematic review and meta-analysis. PLoS ONE 2015; 10(1):e0116079.
Ding C, Yang Z, Wang S, Sun F, Zhan S. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study. Endocrine 2018; 60(2):282-291.
Wu S, Cipriani A, Yang Z, Yang J, Cai T, Xu Y, Quan X, Zhang Y, Chai S, Sun F, Zhan S. The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis. Expert Opinion on Drug Safety 2018;17(3):243-249.